MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from related
party loan
$5,848K
Proceeds from business
combination
$27K
Net cash provided by
financing activities
$5,875K
Net change in cash
and cash...
$8K
Canceled cashflow
$5,867K
Stock-based compensation
$142,435K
Other assets
-$9,851K
Accounts payable
$2,145K
Accrued expenses
$704K
Net cash used in
operating activities
-$5,867K
Canceled cashflow
$155,135K
Net loss
-$160,416K
Prepaid expenses
$586K
Back
Back
Cash Flow
source: myfinsight.com
Semnur Pharmaceuticals, Inc. (SMNR)
Semnur Pharmaceuticals, Inc. (SMNR)